EUVIMEDEUVIMED entdecken
Open Access

PD-1 inhibitor in patients with minimal residual disease who failed donor lymphocyte infusion or interferon after allogeneic haematopoietic stem cell transplantation

Ling Ma, Si-Qi Li, Wei Han, Hai-Xia Fu, Yao Chen, Rui Ma, Yu-Hong Chen, Xiao-Hui Zhang, Lan-Ping Xu, Yu Wang, Chen-Hua Yan, Feng-Rong Wang und 3 weitere

BLOOD CELL THERAPY / The official journal of APBMT · 2025 · 8 (2)

DOI: 10.31547/bct-2024-034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BLOOD CELL THERAPY / The official journal of APBMT, 2025. Verfasst von Ling Ma und 14 weiteren Autor:innen. Beteiligte Einrichtung: Peking University People's Hospital and Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing…. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

acute myeloid leukaemiaallogeneic hematopoietic stem cell transplantationminimal residual diseaseprogrammed death receptor 1 inhibitor

Autor:innen und Institutionen

  • Peking University People's Hospital and Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, C…

Zitieren

APA

Ma, L., Li, S. Q., Han, W., Fu, H. X., Chen, Y., Ma, R., Chen, Y. H., Zhang, X. H., Xu, L. P., Wang, Y., Yan, C. H., Wang, F. R., Mo, X. D., Huang, X. J., & Sun, Y. Q. (2025). PD-1 inhibitor in patients with minimal residual disease who failed donor lymphocyte infusion or interferon after allogeneic haematopoietic stem cell transplantation. BLOOD CELL THERAPY / The official journal of APBMT, 8(2). https://doi.org/10.31547/bct-2024-034

Vancouver

Ma L, Li SQ, Han W, Fu HX, Chen Y, Ma R, et al. PD-1 inhibitor in patients with minimal residual disease who failed donor lymphocyte infusion or interferon after allogeneic haematopoietic stem cell transplantation. BLOOD CELL THERAPY / The official journal of APBMT. 2025;8(2). doi:10.31547/bct-2024-034

BibTeX
@article{Ma2025,
  author = {Ma, Ling and Li, Si-Qi and Han, Wei and Fu, Hai-Xia and Chen, Yao and Ma, Rui and Chen, Yu-Hong and Zhang, Xiao-Hui and Xu, Lan-Ping and Wang, Yu and Yan, Chen-Hua and Wang, Feng-Rong and Mo, Xiao-Dong and Huang, Xiao-Jun and Sun, Yu-Qian},
  title = {PD-1 inhibitor in patients with minimal residual disease who failed donor lymphocyte infusion or interferon after allogeneic haematopoietic stem cell transplantation},
  journal = {BLOOD CELL THERAPY / The official journal of APBMT},
  year = {2025},
  volume = {8},
  number = {2},
  doi = {10.31547/bct-2024-034}
}
Kostenlos starten →